National Guideline Clearinghouse | Pixantrone monotherapy for treating multiply relapsed or refractory aggressive non-Hodgkin's B-cell lymphoma.

full-text ►

National Guideline Clearinghouse | Pixantrone monotherapy for treating multiply relapsed or refractory aggressive non-Hodgkin's B-cell lymphoma.



National Institute for Health and Care Excellence (NICE)

Guideline Title

Pixantrone monotherapy for treating multiply relapsed or refractory aggressive non-Hodgkin's B-cell lymphoma.

Bibliographic Source(s)

National Institute for Health and Care Excellence (NICE). Pixantrone monotherapy for treating multiply relapsed or refractory aggressive non-Hodgkin's B-cell lymphoma. London (UK): National Institute for Health and Care Excellence (NICE); 2014 Feb. 57 p. (Technology appraisal guidance; no. 306).

Guideline Status

This is the current release of the guideline.

This guideline meets NGC's 2013 (revised) inclusion criteria.